• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow Edges Higher; Tigo Energy Shares Plunge

    8/9/23 2:59:16 PM ET
    $BNTC
    $DBTX
    $PALI
    $RENB
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $BNTC alert in real time by email

    U.S. stocks pared some losses toward the end of trading, with the Dow Jones turning higher on Wednesday.

    The Dow traded up 0.05% to 35,332.35 while the NASDAQ fell 0.46% to 13,820.37. The S&P 500, also fell, dropping, 0.07% to 4,496.29.

    Check This Out: Wall Street's Most Accurate Analysts Say Hold These 3 Financial Stocks With Over 5% Dividend Yields

     

    Leading and Lagging Sectors

    • Energy shares jumped by 1.7% on Wednesday.
    • In trading on Wednesday, information technology shares fell 0.7%.

     

    Top Headline

    The Wendy's Company (NASDAQ:WEN) reported upbeat earnings for its second quarter, while sales missed estimates.

    The company reported second-quarter FY23 sales growth of 4.4% year-on-year to $561.57 million, missing the analyst consensus of $566.95 million. Adjusted EPS of $0.28 beat the consensus estimate of $0.27.

    Wendy's continues to expect FY23 adjusted EPS of $0.95 - $1.00 versus the consensus of $0.98.

     

    Equities Trading UP

    • Benitec Biopharma Inc. (NASDAQ:BNTC) shares shot up 70% to $3.28. Benitec Biopharma reported pricing of $30 million underwritten public offering.
    • Shares of Decibel Therapeutics, Inc. (NASDAQ:DBTX) got a boost, shooting 78% to $4.96 after Regeneron announced it will acquire the company.
    • Renovaro Biosciences Inc. (NASDAQ:RENB) shares were also up, gaining 66% to $1.4119 after the company and AI-focused GEDi Cube announced a binding, exclusive letter of intent to merge.

     

    Equities Trading DOWN

    • Palisade Bio, Inc. (NASDAQ:PALI) shares dropped 63% to $0.7102 after the company announced its U.S. Phase 2 PROFILE study evaluating LB1148 for post-surgical abdominal adhesions did not achieve the primary efficacy endpoint.
    • Shares of Tigo Energy, Inc. (NASDAQ:TYGO) were down 44% to $11.90 after the company reported worse-than-expected second-quarter sales results and issued third-quarter revenue guidance below estimates.
    • WeWork Inc. (NYSE:WE) was down, falling 40% to $0.1262 after the company reported worse-than-expected second-quarter financial results.

    Also Check This Out: Disney To Report Earnings After Market Closes Wednesday, Options Traders Anticipate 5.5% Move

     

    Commodities

    In commodity news, oil traded up 1.8% to $84.41 while gold traded down 0.6% at $1,949.20.

    Silver traded down 0.3% to $22.75 on Wednesday while copper rose 0.7% to $3.7920.

     

    Euro zone

    European shares closed higher today. The eurozone’s STOXX 600 rose 0.43%, London’s FTSE 100 rose 0.80% while Spain’s IBEX 35 Index rose 0.57% The German DAX gained 0.49% French CAC 40 rose 0.72% and Italy’s FTSE MIB Index gained 1.31%.

     

    Asia Pacific Markets

    Asian markets closed mixed on Wednesday, with Japan’s Nikkei 225 falling 0.53%, China’s Shanghai Composite Index falling 0.49% and Hong Kong’s Hang Seng Index gaining 0.32%. India’s S&P BSE Sensex, meanwhile, rose 0.1%.

    China's producer prices declined 4.4% year-over-year in July following a 5.4% decline in the previous month, while consumer prices fell by 0.3%% year-over-year in July, versus a flat reading in the prior month.

    Japan’s machine tool orders fell 19.8% year-over-year to JPY 114,251 million in July following a revised 22.2% decline in the prior month.

     

    Economics

    • Mortgage applications in the U.S. declined 3.1% during the first week of August.
    • U.S. crude oil inventories increased by 5.851 million barrels in the week to Aug. 4, 2023, compared to market expectations for a 0.567 million barrel rise, the EIA said.

    Now Read This: Top 3 Tech Stocks That May Fall Off A Cliff

     

    COVID-19 Update

    The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 107,569,370 cases with around 1,170,790 deaths. India confirmed a total of at least 44,996,030 cases and 531,910 deaths, while France reported over 40,138,560 COVID-19 cases with 167,640 deaths. In total, there were at least 693,010,490 cases of COVID-19 worldwide with more than 6,905,650 deaths.

    Get the next $BNTC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BNTC
    $DBTX
    $PALI
    $RENB

    CompanyDatePrice TargetRatingAnalyst
    Palisade Bio Inc.
    $PALI
    1/9/2026$7.00Buy
    B. Riley Securities
    Palisade Bio Inc.
    $PALI
    12/29/2025$25.00Overweight
    Piper Sandler
    Wendy's Company
    $WEN
    12/3/2025$9.00Overweight → Neutral
    Analyst
    Wendy's Company
    $WEN
    10/28/2025$8.00Underperform
    Mizuho
    Wendy's Company
    $WEN
    9/25/2025$7.00Neutral → Sell
    Northcoast
    Wendy's Company
    $WEN
    9/23/2025Buy → Hold
    Argus
    Tigo Energy Inc.
    $TYGO
    7/31/2025$3.00Neutral → Buy
    Roth Capital
    Benitec Biopharma Inc.
    $BNTC
    7/7/2025Buy
    TD Cowen
    More analyst ratings

    $BNTC
    $DBTX
    $PALI
    $RENB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    THE WENDY'S COMPANY REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS AND PROVIDES 2026 OUTLOOK

    Global systemwide sales for the fourth quarter were $3.4 billion, a decrease of 8.3%, and for the full year were $14.0 billion, a decrease of 3.5%.International systemwide sales for the fourth quarter and full year grew 6.2% and 8.1%, respectively.Added 34 net new restaurants in the fourth quarter, bringing total additions to 157 net new restaurants for the full year, an increase of 2.2%.Reported net income for the fourth quarter and full year were $26.5 million and $165.1 million, respectively. Adjusted EBITDA for the fourth quarter and full year were $113.3 million and $522.4 million, respectively.Reported diluted earnings per share for the fourth quarter and full year were $0.14 and $0.85

    2/13/26 7:00:00 AM ET
    $WEN
    Restaurants
    Consumer Discretionary

    Benitec Biopharma Releases Second Quarter 2026 Financial Results and Provides Operational Update

    -The first 4 Patients enrolled into Cohort 1 of the BB-301 Phase 1b/2a treatment study have completed the 12-month statistical follow-up period, and all 4 Completers were formal Responders to BB-301 at the 12-month follow-up timepoint demonstrating durable response to BB-301- -Patient 1 of Cohort 1 completed the 24-month follow-up timepoint, and at the 24-month post-treatment timepoint Patient 1 continued to experience the disease-modifying effects of BB-301, with deepening improvements in post-swallow residue and total dysphagic symptom burden as compared to the 12-month follow-up timepoint- - An update on the Interim clinical results for Cohort 2 is planned for mid-2026- -FDA meeting to

    2/12/26 8:30:00 AM ET
    $BNTC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Tigo Energy to Demo Real-time Active Commissioning Software at IESNA 2026

    New Tigo solar installation and commissioning software combines on-site installation guidance, real-time progress monitoring, and component verification via Tigo EI installer app. Tigo Energy, Inc. (NASDAQ:TYGO) ("Tigo" or "Company"), a leading provider of intelligent solar and energy software solutions, today announced that engineering leaders from Tigo will be at IESNA 2026 to preview a new, real-time active commissioning system designed to get installers to the next job faster, with more confidence, and with fewer service calls and repeat truck rolls. From basic solar-only systems to the most advanced home energy configurations, the new Tigo commissioning system supports installers at

    2/12/26 6:00:00 AM ET
    $TYGO
    Semiconductors
    Technology

    $BNTC
    $DBTX
    $PALI
    $RENB
    SEC Filings

    View All

    $BNTC
    $DBTX
    $PALI
    $RENB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $BNTC
    $DBTX
    $PALI
    $RENB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $BNTC
    $DBTX
    $PALI
    $RENB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Tigo Energy Inc.

    SCHEDULE 13G/A - TIGO ENERGY, INC. (0001855447) (Subject)

    2/13/26 12:44:15 PM ET
    $TYGO
    Semiconductors
    Technology

    Amendment: SEC Form SCHEDULE 13G/A filed by Palisade Bio Inc.

    SCHEDULE 13G/A - PALISADE BIO, INC. (0001357459) (Subject)

    2/13/26 8:50:59 AM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Wendy's Company filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Wendy's Co (0000030697) (Filer)

    2/13/26 7:06:46 AM ET
    $WEN
    Restaurants
    Consumer Discretionary

    Director Williams Donald Allen bought $8,356 worth of shares (5,000 units at $1.67), increasing direct ownership by 87% to 10,728 units (SEC Form 4)

    4 - PALISADE BIO, INC. (0001357459) (Issuer)

    1/21/26 4:05:24 PM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Williams Donald Allen bought $9,400 worth of shares (5,000 units at $1.88), increasing direct ownership by 687% to 5,728 units (SEC Form 4)

    4 - PALISADE BIO, INC. (0001357459) (Issuer)

    1/13/26 9:43:07 PM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Suvretta Capital Management, Llc bought $1,903,133 worth of shares (144,223 units at $13.20) (SEC Form 4)

    4 - Benitec Biopharma Inc. (0001808898) (Issuer)

    12/29/25 7:31:28 PM ET
    $BNTC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Medical Officer Jones Mitchell Lawrence converted options into 8,000 shares and sold $3,481 worth of shares (1,989 units at $1.75), increasing direct ownership by 83% to 13,263 units (SEC Form 4)

    4 - PALISADE BIO, INC. (0001357459) (Issuer)

    2/13/26 8:10:12 PM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    CEO, CFO Finley John David converted options into 13,333 shares and sold $6,818 worth of shares (3,896 units at $1.75), increasing direct ownership by 53% to 27,353 units (SEC Form 4)

    4 - PALISADE BIO, INC. (0001357459) (Issuer)

    2/13/26 8:07:40 PM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 4 filed by Chief Medical Officer Jones Mitchell Lawrence

    4 - PALISADE BIO, INC. (0001357459) (Issuer)

    2/11/26 5:34:45 PM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    B. Riley Securities initiated coverage on Palisade Bio with a new price target

    B. Riley Securities initiated coverage of Palisade Bio with a rating of Buy and set a new price target of $7.00

    1/9/26 9:07:04 AM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Piper Sandler initiated coverage on Palisade Bio with a new price target

    Piper Sandler initiated coverage of Palisade Bio with a rating of Overweight and set a new price target of $25.00

    12/29/25 7:10:24 AM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Wendy's downgraded by Analyst with a new price target

    Analyst downgraded Wendy's from Overweight to Neutral and set a new price target of $9.00

    12/3/25 8:18:18 AM ET
    $WEN
    Restaurants
    Consumer Discretionary

    $BNTC
    $DBTX
    $PALI
    $RENB
    Leadership Updates

    Live Leadership Updates

    View All

    Tigo Energy EI Residential Solar-plus-Storage Solution Certified with Romanian Grid Operators

    With approval from Distribuție Energie Electrică România (DEER), Distribuție Oltenia, and Rețele Electrice, Tigo expands offering in one of Europe's fastest-growing residential solar markets. Tigo Energy, Inc. (NASDAQ: "TYGO") ("Tigo" or "Company"), a leading provider of intelligent solar and energy software solutions, today announced the successful certification of the Tigo EI Residential solar-plus-storage solution with Romanian distribution system operators, further expanding market reach of Tigo products across Europe. Following the successful completion of their respective grid-compliance and certification procedures with Distribuție Energie Electrică Romania (DEER), Distribuție Olte

    2/9/26 12:00:00 AM ET
    $TYGO
    Semiconductors
    Technology

    Tigo Energy Next Gen Software-Enhanced GO Battery Now Available in North America

    Storage system improvements over the EI Battery enable installation twice as fast, taking up 40% less space, with Virtual Power Plant (VPP) program qualification Tigo Energy, Inc. (NASDAQ:TYGO) ("Tigo" or "Company"), a leading provider of intelligent solar and energy software solutions, today announced the availability of the enhanced Tigo GO Battery, strengthening its role in distributed energy management with overall performance improvements and the addition of key features. The GO Battery also now qualifies for participation in select Virtual Power Plant (VPP) programs and has been added to the EnergyHub and Uplight distributed energy resource management (DERMS) platforms. The Tigo GO

    1/29/26 9:00:00 AM ET
    $TYGO
    Semiconductors
    Technology

    Palisade Bio Appoints Leading Global IBD Experts, Laurent Peyrin-Biroulet, MD, PhD and David T. Rubin, MD, to Its Clinical Advisory Board

    Internationally recognized leaders in inflammatory bowel disease bring deep expertise spanning ulcerative colitis, Crohn's disease, and late-stage clinical trial design Appointments strengthen Palisade Bio's clinical strategy as PALI-2108 advances toward Phase 2 development in ulcerative colitis and fibrostenotic Crohn's disease, with a Phase 2 UC IND submission planned for the first half of 2026 Carlsbad, CA, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (NASDAQ:PALI) ("Palisade" or the "Company"), a clinical-stage biopharmaceutical company developing next-generation, once-daily, oral PDE4 inhibitor prodrugs designed for targeted delivery to the terminal ileum and colon, today an

    1/29/26 8:45:00 AM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $BNTC
    $DBTX
    $PALI
    $RENB
    Financials

    Live finance-specific insights

    View All

    THE WENDY'S COMPANY REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS AND PROVIDES 2026 OUTLOOK

    Global systemwide sales for the fourth quarter were $3.4 billion, a decrease of 8.3%, and for the full year were $14.0 billion, a decrease of 3.5%.International systemwide sales for the fourth quarter and full year grew 6.2% and 8.1%, respectively.Added 34 net new restaurants in the fourth quarter, bringing total additions to 157 net new restaurants for the full year, an increase of 2.2%.Reported net income for the fourth quarter and full year were $26.5 million and $165.1 million, respectively. Adjusted EBITDA for the fourth quarter and full year were $113.3 million and $522.4 million, respectively.Reported diluted earnings per share for the fourth quarter and full year were $0.14 and $0.85

    2/13/26 7:00:00 AM ET
    $WEN
    Restaurants
    Consumer Discretionary

    Tigo Energy Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on Tuesday, February 24, 2026 at 4:30 p.m. ET

    Tigo Energy also announced attendance of upcoming investor conferences Tigo Energy Inc. (NASDAQ:TYGO) ("Tigo" or the "Company"), a leading provider of intelligent solar and energy software solutions, will hold a conference call on Tuesday, February 24, 2026 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss its financial results for the fourth quarter and full year ended December 31, 2025. Financial results will be issued in a press release prior to the call. Tigo management will host the presentation, followed by a question-and-answer period. Date: Tuesday, February 24, 2026 Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time) Registration Link Conference Call: Click here

    2/10/26 4:05:00 PM ET
    $TYGO
    Semiconductors
    Technology

    The Wendy's Company to Report Fourth Quarter and Full Year 2025 Results on February 13

    DUBLIN, Ohio, Jan. 15, 2026 /PRNewswire/ -- The Wendy's Company (NASDAQ:WEN) will release its fourth quarter and full year 2025 results and share its 2026 financial outlook before the market opens on Friday, February 13. The Company will host a conference call that same day at 8:30 a.m. ET, with a simultaneous webcast accessible from the Company's Investor Relations website at www.irwendys.com. The related presentation materials will also be available on the Company's Investor Relations website. The live conference call will be available by telephone at (844) 200-6205 for domestic callers and (929) 526-1599 for international callers, both using event ID 383100. A replay of the webcast will b

    1/15/26 4:30:00 PM ET
    $WEN
    Restaurants
    Consumer Discretionary

    $BNTC
    $DBTX
    $PALI
    $RENB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Benitec Biopharma Inc.

    SC 13G/A - Benitec Biopharma Inc. (0001808898) (Subject)

    12/6/24 1:47:28 PM ET
    $BNTC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Benitec Biopharma Inc.

    SC 13D/A - Benitec Biopharma Inc. (0001808898) (Subject)

    11/18/24 4:36:00 PM ET
    $BNTC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Palisade Bio Inc.

    SC 13G - PALISADE BIO, INC. (0001357459) (Subject)

    11/14/24 3:35:13 PM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care